SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Schedule of segment revenues and profit

Segment revenues and profits for the three months ended March 31, 2021 and 2020 were as follows:

	Three Months Ended March 31,
(in millions)	2021		2020
Revenues:
Bausch + Lomb	$	881	$	875
Salix	472		477
International Rx	306		291
Ortho Dermatologics	141		131
Diversified Products	227		238
	$	2,027	$	2,012
Segment profits:
Bausch + Lomb	$	239	$	263
Salix	327		319
International Rx	109		98
Ortho Dermatologics	70		47
Diversified Products	171		167
	916		894
Corporate	(181)		(156)
Amortization of intangible assets	(357)		(436)
Goodwill impairments	(469)		—
Asset impairments	(148)		(14)
Restructuring, integration and separation costs	(12)		(4)
Other income (expense), net	30		(36)
Operating (loss) income	(221)		248
Interest income	2		7
Interest expense	(368)		(396)
Loss on extinguishment of debt	(5)		(24)
Foreign exchange and other	1		(13)
Loss before (provision for) benefit from income taxes	$	(591)	$	(178)

Schedule of revenues by segment and product category

Revenues by segment and product category were as follows:

	Three Months Ended March 31, 2021
(in millions)	Bausch + Lomb		Salix		International Rx		Ortho Dermatologics		Diversified Products		Total
Pharmaceuticals	$	125	$	470	$	59	$	65	$	177	$	896
Devices	382		—		—		72		—		454
OTC	316		—		25		—		2		343
Branded and Other Generics	51		—		212		—		47		310
Other revenues	7		2		10		4		1		24
	$	881	$	472	$	306	$	141	$	227	$	2,027

	Three Months Ended March 31, 2020
(in millions)	Bausch + Lomb		Salix		International Rx		Ortho Dermatologics		Diversified Products		Total
Pharmaceuticals	$	138	$	477	$	66	$	76	$	182	$	939
Devices	341		—		—		51		—		392
OTC	321		—		26		—		2		349
Branded and Other Generics	68		—		188		—		50		306
Other revenues	7		—		11		4		4		26
	$	875	$	477	$	291	$	131	$	238	$	2,012

Schedule of revenue attributed to a geographic region

Revenues are attributed to a geographic region based on the location of the customer and were as follows:

	Three Months Ended March 31,
(in millions)	2021		2020
U.S. and Puerto Rico	$	1,162	$	1,211
China	110		58
Canada	76		90
Mexico	69		41
Egypt	66		58
Poland	62		73
Japan	60		54
France	54		47
Germany	42		44
Russia	31		34
United Kingdom	25		23
South Korea	20		17
Other	250		262
	$	2,027	$	2,012

Schedule of customers that accounted for 10% or more of total revenue

Customers that accounted for 10% or more of total revenues were as follows:

	Three Months Ended March 31,
	2021	2020
AmerisourceBergen Corporation	18%	19%
McKesson Corporation (including McKesson Specialty)	16%	16%
Cardinal Health, Inc.	12%	13%